Literature DB >> 28986775

Timeline metastatic progression: in the wake of the « seed and soil » theory.

Aymeric Amelot1,2, Louis-Marie Terrier3, Jean-Jacques Mazeron4,5, Charles-Ambroise Valery6,4, Philippe Cornu6,4, Alexandre Carpentier6,4, Marc Leveque6,4.   

Abstract

Little is known about the natural history of cancer and its evolution to metastasis. Paget was the first to postulate the important role played by microenvironment in metastasis progression. Since, the concept of his "seed and soil" theory has been supported and confirmed. Understanding the chronology and natural course that underlie metastasis is mandatory to deepen this concept and to progress in the development of novel therapeutic strategies. A total of 413 patients who underwent treatment for brain metastasis (2013-2016) were included. The identification of previous and newly diagnosed metastasis was made during the clinical and imaging follow-up. We identified 910 metastases in our series. The 2-, 5-, and 10-year survival estimates were 80% (SD 2), 59.1% (3), and 36% (4), respectively. The median time for first metastasis, referred as metastasis-free survival (MFS) was 15.2 months (SD 1.47). MFS were determined for each metastasis location and were as follows: 7.2 months (SD 8.0) for bone, adrenal 8.4 months (SD 9.4) for adrenal, 13.2 months (SD 1.7) for brain, 14.6 months (SD 5.4) for liver, 25.7 months (SD 11.7) for pleura, 27.7 months (SD 15.9) for peritoneum, 29.8 months (SD 7.2) for spine, 30.2 months (SD 5.2) for lungs, and 54.2 months (SD 12.4) for skin (p < 0.009 log rank). We identified a metastatic timeline process for breast cancer (p < 0.0001 log rank (Mantel-Cox)) and furthermore according to breast subtype cancer (p < 0.0001). We suggest that in addition to Paget's theory, a timeline and a natural history of metastasis exist in patients with cancer. We suppose that some, but not all, primary cancers follow chronological and scheduled metastatic processes to invade organs.

Entities:  

Keywords:  Chronology; Metastasis; Metastatic progression; Survival; Timeline

Mesh:

Substances:

Year:  2017        PMID: 28986775     DOI: 10.1007/s12032-017-1045-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  45 in total

1.  The organ selectivity of experimentally induced metastases in rats.

Authors:  E D SUGARBAKER
Journal:  Cancer       Date:  1952-05       Impact factor: 6.860

Review 2.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 3.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

4.  Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients.

Authors:  B Szekely; Zs I Nagy; Zs Farago; O Kiss; G Lotz; K A Kovacs; L Madaras; N Udvarhelyi; M Dank; Gy Szentmartoni; Zs Baranyai; L Harsanyi; A M Tőkés; Jozsef Timar; A M Szasz; J Kulka
Journal:  Clin Exp Metastasis       Date:  2016-11-24       Impact factor: 5.150

Review 5.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Metastatic sites and survival in lung cancer.

Authors:  M Riihimäki; A Hemminki; M Fallah; H Thomsen; K Sundquist; J Sundquist; K Hemminki
Journal:  Lung Cancer       Date:  2014-08-02       Impact factor: 5.705

Review 7.  Overview of resistance to systemic therapy in patients with breast cancer.

Authors:  Ana Maria Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 8.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 9.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

Review 10.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

View more
  3 in total

1.  Can anticancer chemotherapy promote the progression of brain metastases?

Authors:  Aymeric Amelot; Louis-Marie Terrier; Bertrand Mathon; Ann-Rose Cook; Jean-Jacques Mazeron; Charles-Ambroise Valery; Philippe Cornu; Marc Leveque; Alexandre Carpentier
Journal:  Med Oncol       Date:  2018-02-09       Impact factor: 3.064

2.  Circulatory shear stress induces molecular changes and side population enrichment in primary tumor-derived lung cancer cells with higher metastatic potential.

Authors:  Keila Alvarado-Estrada; Lina Marenco-Hillembrand; Sushila Maharjan; Valerio Luca Mainardi; Yu Shrike Zhang; Natanael Zarco; Paula Schiapparelli; Hugo Guerrero-Cazares; Rachel Sarabia-Estrada; Alfredo Quinones-Hinojosa; Kaisorn L Chaichana
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

3.  An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.

Authors:  Junfeng Wang; Jianying Lou; Lei Fu; Qu Jin
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.